Clinical Trial Update: Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating EBV-TCR-T cells for Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation. Recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection After Allogeneitic Hematopoietic Stem Cell Transplantation

Drugs mentioned

• EBV-TCR-T Cells (EBV-specific T-cell receptor-engineered T cells)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: EBV Infection After Allogenic HSCT | Phase 1 | Status: RECRUITING